LAURA PERRIN: Open Payments
NPI 1720561715 · MENDHAM, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 36 payments from 13 companies in 2025. Trend: 2023 $183 · 2024 $1,007 · 2025 $766
Food & beverage: $766
| Company | Payments | Amount |
|---|---|---|
| Vifor Pharma, Inc. | 8 | $133 |
| Novartis Pharmaceuticals Corporation | 7 | $127 |
| Ardelyx, Inc. | 6 | $98 |
| Travere Therapeutics, Inc. | 1 | $94 |
| Amgen Inc. | 1 | $93 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Novo Nordisk Inc | 2 | $31 |
| Fresenius USA Marketing, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: Veltassa, IBSRELA, TAVNEOS, Kerendia, JYNARQUE, VELPHORO, SHINGRIX, FABRAZYME.
Industry payments across NJ — which companies pay providers there.
